Kwangdong to develop a new anti-leukemia drug.

Published: 2005-11-10 06:58:00
Updated: 2005-11-10 06:58:00
Kwangdong pharmaceutical company announced to develop a new mono-clonal antibody for the treatment of leukemia with the research team of SNU Medical College and Dinona, an antibody research company.

The technology of the mono clonal antibody therapy was aimed at a new therapeutic approach for ...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.